Abbott Laboratories (NYSE:ABT) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 6.98% to $0.46 in the quarter versus EPS of $0.43 in the year-earlier quarter. Revenue Decreased 44.47% to $5.45 billion from the year-earlier quarter.
Abbott Laboratories reported adjusted EPS income of $0.46 per share. By that measure, the company beat the mean analyst estimate of $0.44. It missed the average revenue estimate of $5.52 billion.